Marco Ruella

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Marco Ruella

Sep 14, 2024, 17:46 | Insight

Kai Rejeski: Second Primary Malignancies following CAR T-cell therapy

Kai Rejeski shared a post on X about a recent paper by Tobias Tix et…

Aug 12, 2024, 01:20 | Blog

Using CRISPR technology to enhance CAR-T cells

Patrick Hwu shared on X: "How do we make more effective CAR-T cells? The Marco Ruella…

Jul 28, 2024, 14:24 | Insight

10 papers suggested by Wafik S. El-Deiry

Wafik S. El-Deiry, Director of the Legorreta Cancer Center of Brown University and Associate Dean for…

Jul 21, 2024, 21:50 | Insight

Marco Ruella: CD5 deletion enhances CART immunotherapy in multiple solid and liquid cancer models

Marco Ruella, Assistant Professor Of Medicine and Scientific Director Lymphoma Program at the University of…

Jun 13, 2024, 06:51 | Insight

Racial disparities among patients treated with CART-cell therapy for lymphoma - Penn Medicine

Penn Medicine shared a post on X: “A new NEJM Evidence study found racial disparities…

Jun 12, 2024, 14:11 | Insight

Maria Hendricks: CAR-T therapy is considered a cure for some types of cancer

Maria Hendricks, Director of Clinical Research Operations for the Abramson Cancer Center (ACC) Clinical Research…

Apr 29, 2024, 17:36 | Blog

Kate Cwynarski: Fantastic talk by Marco Ruella on CAR-T

Kate Cwynarski, Consultant Haematologist at University College London Hospitals NHS Foundation Trust, recently shared on…

Dec 17, 2023, 01:37 | Blog

Marco Ruella: So excited to see our discovery make it into human trials!

Marco Ruella, Assistant Professor Of Medicine and Scientific Director Lymphoma Program at University of Pennsylvania,…

All: 8 Posts: 1 - 100